KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Net Income (2016 - 2025)

Elevance Health (ELV) has disclosed Net Income for 16 consecutive years, with $1.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Net Income rose 17.76% to $1.2 billion in Q3 2025 year-over-year; TTM through Dec 2025 was -$3.1 billion, a 151.42% decrease, with the full-year FY2024 number at $6.0 billion, changed 0.33% from a year prior.
  • Net Income was $1.2 billion for Q3 2025 at Elevance Health, up from -$3.9 billion in the prior quarter.
  • In the past five years, Net Income ranged from a high of $2.3 billion in Q2 2024 to a low of -$44.4 billion in Q4 2021.
  • A 5-year average of -$1.5 billion and a median of $1.3 billion in 2023 define the central range for Net Income.
  • Peak YoY movement for Net Income: tumbled 8149.55% in 2021, then skyrocketed 185.41% in 2022.
  • Elevance Health's Net Income stood at -$44.4 billion in 2021, then soared by 102.01% to $890.0 million in 2022, then fell by 6.63% to $831.0 million in 2023, then plummeted by 50.3% to $413.0 million in 2024, then soared by 187.41% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Net Income are $1.2 billion (Q3 2025), -$3.9 billion (Q2 2025), and -$367.0 million (Q1 2025).